Refer a patient.

Have a patient with Pompe disease who may be interested in the Comet Study?

The purpose of the Comet Study is to compare the safety and efficacy of an investigational enzyme replacement therapy with the currently approved enzyme replacement therapy in patients with late-onset Pompe disease.

If you have a patient who may be interested and you think may qualify, you may refer your patient to any of the study sites listed.

AZ

Barrow Neurological Institute, St. Joseph's Hospital
Phoenix, AZ

CA

University of California Irvine
Orange, CA
Stanford University School of Medicine
Palo Alto, CA

FL

University of Florida
Gainesville, FL

GA

Emory University
Decatur, GA

IA

University of Iowa
Iowa City, IA

IL

Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL

KS

University of Kansas Medical Center
Kansas City, KS

MA

Massachusetts General Hospital
Boston, MA

Michigan

Children's Hospital Of Michigan
Detroit, Michigan

MN

University of Minnesota
Minneapolis, MN

NC

Duke University Medical Center
Durham, NC

NY

Northwell Health
Great Neck, NY
NYU - Neurogenetics
New York, NY
Regional Medical Genetics Center of New York
Valhalla, NY

OH

University of Cincinnati
Cincinnati, OH

OR

Oregon Health Sciences University
Portland, OR

Pa

University of Pittsburgh Medical Center
Pittsburgh, Pa
 

PA

Penn State Milton S. Hershey Medical Center
Hershey, PA

TX

Institute of Metabolic Disease - Baylor Research Institute
Dallas, TX

UT

University of Utah
Salt Lake City, UT

VA

O and O Alpan LLC
Fairfax, VA

See If You May Qualify

This website is not intended to replace the informed consent process or the advice of your doctor.